GlaxoSmithKline Pharmaceuticals informs about board meeting

19 Jan 2017 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on February 11, 2017, to consider and approve Un-Audited Financial Results for the quarter and nine months ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2624.40 -26.45 (-1.00%)
26-Feb-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.90
Dr. Reddys Lab 1317.65
Cipla 1351.55
Zydus Lifesciences 935.25
Lupin 2315.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×